Active Shortage Injection Cardiovascular

Lidocaine Hydrochloride Inje · #4 of 35 active shortages by FDA posting duration

Brand: LIDOCAINE HYDROCHLORIDE AND DEXTROSE

FDA lists Lidocaine Hydrochloride Inje as Active Shortage (Baxter Healthcare).

Availability on file: Available

Lidocaine Hydrochloride Injection: Active Shortage

Available 71 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Lidocaine Hydrochloride Injection
Manufacturer
Baxter Healthcare
Dosage Form
Injection
Presentation
Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02)
Package NDC
0338-0411-02

Status & Timeline

Status
Active Shortage
Availability
Available
First Reported
Oct 25, 2017
Last Updated
Mar 4, 2026
Therapeutic Category
Cardiovascular

Row fields from the FDA Drug Shortages database via openFDA.

Full Drug Profile

lidocaine topical

Side effects, interactions, warnings & more

View Profile

Nearby, Other Lidocaine Shortage Records